Welcome to our dedicated page for AEMETIS SEC filings (Ticker: AMTX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AEMETIS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AEMETIS's regulatory disclosures and financial reporting.
A Form 144 notice shows a proposed sale of 26,452 shares of common stock of the issuer via Raymond James & Associates on 08/14/2025, with an aggregate market value of $66,923.56. The shares reported for sale were granted as restricted stock units (RSUs) by the issuer on 01/07/2021 (1,300 shares), 04/08/2021 (12,152 shares), 11/18/2021 (5,000 shares), and 08/18/2022 (8,000 shares). The filer reports no securities sold during the past 3 months and indicates payment for these proposed sales will be cash. The filing includes the standard representation that the seller does not possess undisclosed material information about the issuer.